Zhang, J

delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. [electronic resource] - Brain research Dec 2000 - 143-53 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0006-8993

10.1016/s0006-8993(00)02906-1 doi


3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer--pharmacology
Analgesics, Non-Narcotic--pharmacology
Analgesics, Opioid--pharmacology
Animals
Cells, Cultured
Cytoprotection--drug effects
Embryo, Mammalian
Enkephalin, Ala(2)-MePhe(4)-Gly(5)---pharmacology
Enkephalin, Leucine-2-Alanine--pharmacology
Excitatory Amino Acid Agonists--pharmacology
Female
Glutamic Acid--pharmacology
L-Lactate Dehydrogenase--drug effects
Naltrexone--analogs & derivatives
Narcotic Antagonists--pharmacology
Neocortex
Neurons--drug effects
Pregnancy
Rats
Rats, Sprague-Dawley
Receptors, Opioid, delta--drug effects
Receptors, Opioid, kappa--drug effects
Receptors, Opioid, mu--drug effects